ABP
Price
$0.21
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Capitalization
12.34M
MNKD
Price
$4.35
Change
+$0.05 (+1.16%)
Updated
Jun 6, 10:52 AM (EDT)
Capitalization
1.31B
61 days until earnings call
Interact to see
Advertisement

ABP vs MNKD

Header iconABP vs MNKD Comparison
Open Charts ABP vs MNKDBanner chart's image
Abpro Holdings
Price$0.21
Change-$0.00 (-0.00%)
Volume$628.47K
Capitalization12.34M
MannKind
Price$4.35
Change+$0.05 (+1.16%)
Volume$1.04K
Capitalization1.31B
ABP vs MNKD Comparison Chart
Loading...
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABP vs. MNKD commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABP is a Hold and MNKD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ABP: $0.20 vs. MNKD: $4.30)
Brand notoriety: ABP and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABP: 5% vs. MNKD: 59%
Market capitalization -- ABP: $12.34M vs. MNKD: $1.31B
ABP [@Biotechnology] is valued at $12.34M. MNKD’s [@Biotechnology] market capitalization is $1.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABP’s FA Score shows that 1 FA rating(s) are green whileMNKD’s FA Score has 0 green FA rating(s).

  • ABP’s FA Score: 1 green, 4 red.
  • MNKD’s FA Score: 0 green, 5 red.
According to our system of comparison, MNKD is a better buy in the long-term than ABP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABP’s TA Score shows that 3 TA indicator(s) are bullish while MNKD’s TA Score has 6 bullish TA indicator(s).

  • ABP’s TA Score: 3 bullish, 3 bearish.
  • MNKD’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, MNKD is a better buy in the short-term than ABP.

Price Growth

ABP (@Biotechnology) experienced а -12.88% price change this week, while MNKD (@Biotechnology) price change was +4.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.36%. For the same industry, the average monthly price growth was +17.10%, and the average quarterly price growth was +3.20%.

Reported Earning Dates

ABP is expected to report earnings on Apr 15, 2025.

MNKD is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+11.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNKD($1.31B) has a higher market cap than ABP($12.3M). MNKD YTD gains are higher at: -33.126 vs. ABP (-88.659). MNKD has higher annual earnings (EBITDA): 82.6M vs. ABP (-17.4M). MNKD has more cash in the bank: 182M vs. ABP (13.6K). ABP has less debt than MNKD: ABP (160K) vs MNKD (47.2M). MNKD has higher revenues than ABP: MNKD (298M) vs ABP (122K).
ABPMNKDABP / MNKD
Capitalization12.3M1.31B1%
EBITDA-17.4M82.6M-21%
Gain YTD-88.659-33.126268%
P/E RatioN/A43.00-
Revenue122K298M0%
Total Cash13.6K182M0%
Total Debt160K47.2M0%
FUNDAMENTALS RATINGS
MNKD: Fundamental Ratings
MNKD
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
46
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABPMNKD
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
19%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
42%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 10 days ago
48%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GIIYX13.64N/A
N/A
GuideStone Funds Intl Eq Idx Instl
FIKVX13.83N/A
N/A
Fidelity Advisor Asset Manager 20% Z
LHCAX18.13N/A
N/A
Lord Abbett Health Care A
JNVYX18.53N/A
N/A
Jensen Quality Mid Cap Y
BBMIX11.48N/A
N/A
BBH Select Series - Mid Cap I

ABP and

Correlation & Price change

A.I.dvisor tells us that ABP and NGNE have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ABP and NGNE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABP
1D Price
Change %
ABP100%
-3.88%
NGNE - ABP
33%
Poorly correlated
+6.00%
FBIO - ABP
30%
Poorly correlated
+2.16%
MNKD - ABP
27%
Poorly correlated
-1.15%
QSI - ABP
27%
Poorly correlated
-8.86%
PHAT - ABP
26%
Poorly correlated
+0.21%
More

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with VCYT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
-1.15%
VCYT - MNKD
44%
Loosely correlated
-1.17%
LXRX - MNKD
42%
Loosely correlated
+8.86%
INSM - MNKD
40%
Loosely correlated
-1.29%
GBIO - MNKD
38%
Loosely correlated
-5.63%
BLUE - MNKD
38%
Loosely correlated
N/A
More